Monthly update to the list of new safety and effectiveness reviews for health products
The list of new safety and effectiveness reviews has been updated and now includes safety reviews initiated between March 1 and 31, 2026. The next update is scheduled for June 2026.
Health Product InfoWatch, April 2026
Safety brief: Falsely elevated digoxin levels; Product monograph update: Taro-Melphalan
Health Product InfoWatch, April 2026
Safety brief: Falsely elevated digoxin levels; Product monograph update: Taro-Melphalan
Monthly update to the Canada Vigilance adverse reaction online database
The data presented in the Canada Vigilance Adverse Reaction Online Database has been updated and now includes information received by Health Canada up to December 31, 2025. The next update of data is scheduled for early May, 2026.
Health Product InfoWatch, April 2026
Safety brief: Falsely elevated digoxin levels; Product monograph update: Taro-Melphalan
Monthly update to the Canada Vigilance adverse reaction online database
The data presented in the Canada Vigilance Adverse Reaction Online Database has been updated and now includes information received by Health Canada up to December 31, 2025. The next update of data is scheduled for early May, 2026.